We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×

Can Avid Hyperaccumulating Plants like Hemp be Realistically Used as a Source of Medicinal Cannabinoids? Part 2: The Importance of Testing

The second part of this series examines industrial and medical applications of hemp and emphasize the importance of regular testing for heavy metals to ensure maximum consumer safety.

Read More

A Microdosing High is Mostly a Placebo Effect, Psychedelic Study Suggests

People may not have to microdose psychedelics to feel their wellbeing benefits – they just have to believe they’ve microdosed them, according to researchers from Imperial College London.

Read More

Cannabis Can Cause “Rebound” Migraine Headaches, Study Finds

Migraine sufferers who use cannabis for pain relief may be at higher odds of developing a “rebound” headache, according to new research from Stanford University.

Read More

Virginia Legislature Legalizes Recreational Cannabis, But Sales Won’t Start Until 2024

The legalization bill would allow adults over 21 to possess up to 1 ounce (28 grams) of cannabis from January 1, 2024.

Read More

How Does Cannabis Vapor Testing Work?

Cannabis vapor testing is quickly becoming the next frontier of marijuana analysis. But how does it work?

Read More

High-CBD Hemp Crops Are Mostly Marijuana, Genetic Study Finds

Hemp crops may have more in common with recreational, “drug-type” varieties of cannabis than previously thought, according to new research from the University of Minnesota.

Read More

The Risks and Rewards of Different Cannabis Separation Techniques

Alisia Ratliff, CEO of Victus Capital Ventures, explores the world of cannabis separation techniques – the good, the bad, and the expensive.

Read More

Behind the World-First Export of Jamaican Psilocybin Mushrooms

The biotech and life sciences company Mydecine Innovations Group recently announced it had completed its first commercial export of legal psychedelic psilocybin mushrooms from Jamaica to Canada. Technology Networks caught up with the company's chief scientific officer, Rob Roscow, to find out more.

Read More

Over Three-quarters of CBD Topicals Don’t Contain Advertised Amounts of CBD, Study Finds

Around 77 percent of tested CBD topical products don't contain the correct amount of CBD advertised on the product’s label, according to a new investigation from Leafreport.

Read More

 
Advertisement